The science of medical drugs has grown as an essential element in the prevention, diagnosis, and treatment of diseases, along with medical science, and has backgrounds, equaling the human history.

 

Today, the pharmaceutical sciences cover a wide range of drug molecules, vaccines and new drug combinations, each of which, account for a large part of the economy and healthcare exchanges.

 

Studies on the production of new drugs are one of the costliest parts of the healthcare studies, and each year new pharmaceutical patents, as the most expensive health care interventions, change the treatment of diseases. Therefore, localizing the science in this area, appears to be a requirement for proceeding towards attaining “affordable” and “accessible” healthcare.

 

The Salam Group intends to invest in pharmaceutical sciences in order to create a knowledge-based foundation for the development and production of medical drugs, which will lead to improvements in the quality of healthcare.

 

 

 

Darousazi Taha Company:

 

 

Sarmayegozari Sanaye Mosharekati Taha Company, in 2016, founded the largest facility for production of “Effective Ingredients for Hormonal Drugs” in Iran; in the City of Sabzevar (Khorasan Razavi Province), and brought it into production the same year. This complex is located on an area of 20,000 square meters, and encompasses a production hall for the production of various types of hormonal molecules, three cleanroom halls with a total area of 950 square meters, Micronize System and three Laboratory Units (Classic, Instrumental and Microbiological) Septic Tank Farm Purification Unit, and solvent recovery unit with distillation tower. This company could produce four molecules of, Betamethasone Valerate, Hydrocortisone, Medroxyprogesterone Acetate, and Progesterone, and presently it could produce other substances such as Conjugated Estrogens, Methylprednisolone, and Prednisolone.

 

Darousazi Taha Company, in 2017, was recognized as a knowledge-based company by the “Office of Islamic Republic of Iran’s Vice President for Science and Technology”. In 2018, in its development plan, the unit for the production of final products of Semi-Solid Drugs in the form of suppositories, with a capacity of 10,000 pcs per hour, was established. Presently, the company is studying setting up an “IV Solutions & IV Solutions Bags” and “Dialysate Fluid for Hemodialysis” production unit.

 

Factory Address:

Sabzevar, Km 12, Tehran Road, after the Steer Industrial Township

Phone:

+98 51 44333336 &7

Website:

tahapharmacy.com